The latest price target for Augmedix (NASDAQ:AUGX) was reported by Lake Street on July 22, 2024. The analyst firm set a price target for $0.00 expecting AUGX to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Augmedix (NASDAQ:AUGX) was provided by Lake Street, and Augmedix downgraded their hold rating.

The last upgrade for Augmedix Inc happened on April 9, 2024 when Evercore ISI Group raised their price target to $5. Evercore ISI Group previously had an in-line for Augmedix Inc.

The last downgrade for Augmedix Inc happened on July 22, 2024 when Lake Street changed their price target from N/A to N/A for Augmedix Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Augmedix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Augmedix was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.

While ratings are subjective and will change, the latest Augmedix (AUGX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Augmedix (AUGX) is trading at is $2.33, which is out of the analyst’s predicted range.